Search results for "Mines"

showing 10 items of 2609 documents

Sympathetic Overactivity and 24-Hour Blood Pressure Pattern in Hypertensives with Chronic Renal Failure

1995

In order to assess the activity of the sympathetic system and to evaluate the 24-h blood pressure pattern in hypertensives with chronic renal failure (CRF), 12 CRF patients and 16 essential hypertensives (EHs) were studied. In all subjects, plasma samples for catecholamines and renin activity were obtained both in the basal condition and after standing, and 24-h blood pressure monitoring (ABPM) was performed. The 24-h mean blood pressure results were quite similar between CRFs and EHs. In 50% of the CRFs, ABPM showed a nighttime decrease in diastolic BP (DBP) greater than 10%, while in the remaining 50% the ABPM indicated a nondipper blood pressure pattern. Of the 16 EHs, 4 had a nighttime …

medicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemEpinephrineDiastoleBlood PressureCritical Care and Intensive Care MedicinePlasma renin activityNorepinephrineBasal (phylogenetics)CatecholaminesInternal medicineBlood plasmaHumansMedicinebusiness.industryGeneral MedicineBlood Pressure Monitoring AmbulatoryCircadian RhythmMean blood pressureBlood pressuremedicine.anatomical_structureEndocrinologyNephrologyHypertensionCatecholamineKidney Failure Chronicbusinessmedicine.drugRenal Failure
researchProduct

Managing Bleeding Complications in Patients Treated with the Old and the New Anticoagulants

2010

An increasing number of patients receive anticoagulant therapy to prevent and treat arterial or venous thromboembolism. The major complication of anticoagulant therapy is the increase of the individual bleeding risk. All anticoagulant drugs can cause haemorrhages, that can sometimes be life-threatening. Although heparins and the vitamin K antagonists have been the most widely used anticoagulants for decades, the correct management of bleeding complications associated with these agents has been poorly studied. More recently, new anticoagulant drugs, both parenteral and oral, have been approved for clinical use. Currently, none of these new agents has a specific antidote, and little advise ca…

medicine.medical_specialtyVitamin Kmedicine.drug_classMorpholinesHemorrhageFactor VIIaThiophenesVitamin kFondaparinuxDabigatranRivaroxabanPolysaccharidesRisk FactorsDrug DiscoverymedicineHumansProtaminesIntensive care medicinePharmacologyRivaroxabanHeparinbusiness.industryAntithrombinAnticoagulantAnticoagulantsHeparinRecombinant ProteinsDabigatranFondaparinuxbeta-AlanineBenzimidazolesComplicationbusinessBleeding anticoagulantsmedicine.drugCurrent Pharmaceutical Design
researchProduct

Acute oral administration of low doses of methylphenidate targets calretinin neurons in the rat septal area.

2015

Methylphenidate (MPD) is a commonly administered drug to treat children suffering from attention deficit hyperactivity disorder (ADHD). Alterations in septal driven hippocampal theta rhythm may underlie attention deficits observed in these patients. Amongst others, the septo-hippocampal connections have long been acknowledged to be important in preserving hippocampal function. Thus, we wanted to ascertain if methylphenidate administration, which improves attention in patients, could affect septal areas connecting with hippocampus. We used low and orally administered methylphenidate doses (1.3; 2.7 and 5mg/Kg) to rats what mimics the dosage range in humans. In our model, we observed no effec…

medicine.medical_specialtyattention deficity hyperactivity disorderNeuroscience (miscellaneous)HippocampusStriatumNucleus accumbensHippocampal formationcalcium binding proteinslcsh:RC321-571lcsh:QM1-695Cellular and Molecular NeuroscienceCatecholaminesTheta rhythmInternal medicinemedicineADHDTheta Rhythmlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchbiologyTyrosine hydroxylasebusiness.industryDopaminergiclcsh:Human anatomyseptumEndocrinologybiology.proteinMethylphenidateAnatomyCalretininbusinessCalcium binding proteinsNeuroscienceParvalbuminNeuroscienceFrontiers in Neuroanatomy
researchProduct

Clinical pharmacokinetics of atenolol — A review

1982

Atenolol is a hydrophilic betareceptor blocking drug, which is predominantly eliminated via the kidneys, only about 5% of the atenolol is metabolised by the liver. After oral administration atenolol is incompletely absorbed from the intestine, so about 50% of the beta blocker are finally biovailable. In plasma only 3% of atenolol are protein-bound. There exists a linear relationship between the atenolol plasma levels and the degree of beta blocking effect measured by inhibition of the exercise-induced tachycardia. No correlation was found between plasma levels of atenolol and blood pressure lowering activity of the drug. After oral administration elimination half life of atenolol is calcula…

medicine.medical_specialtymedicine.drug_classAdministration OralBiological AvailabilityRenal functionPharmacologyKidneyIntestinal absorptionPropanolaminesPharmacokineticsRenal DialysisOral administrationInternal medicinemedicineHumansDrug InteractionsPharmacology (medical)cardiovascular diseasesBeta blockerPharmacologyChemistryLiver DiseasesKidney metabolismAtenololKineticsEndocrinologyAtenololIntestinal AbsorptionInjections IntravenousKidney DiseasesBiological half-lifecirculatory and respiratory physiologymedicine.drugEuropean Journal of Drug Metabolism and Pharmacokinetics
researchProduct

Effects of indomethacin on muscarinic inhibition of endogenous noradrenaline release from rat isolated trachea

1993

The release of endogenous noradrenaline from rat isolated tracheae was evoked by electrical field stimulation (3 Hz, 540 pulses) in the presence of yohimbine, desipramine and tyrosine. The muscarine receptor agonist oxotremorine concentration-dependently inhibited the evoked release of noradrenaline by 95% at 1 μmol/l, EC50 values in two series of experiments 41 and 57 nmol/l, respectively. The effect of oxotremorine was antagonized by the non-selective muscarine receptor antagonist scopolamine (10–1000 nmol/l) in a manner suggesting a simple competitive interaction (slope of Schild plot −0.94; pA2 value 8.88). However, the M2 selective muscarine receptor antagonist methoctramine (0.1–10 μm…

medicine.medical_specialtymedicine.drug_classIndomethacinDiaminesIn Vitro TechniquesRats Sprague-DawleyNorepinephrinechemistry.chemical_compoundInternal medicineMuscarinic acetylcholine receptormedicineOxotremorineMethoctramineAnimalsPharmacologyMuscarineOxotremorineGeneral MedicineMuscarinic acetylcholine receptor M1Receptor antagonistReceptors MuscarinicPirenzepineRatsTracheaSchild regressionEndocrinologychemistryProstaglandinsFemalemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

CHF2819: Pharmacological profile of a novel acetylcholinesterase inhibitor

2002

CHF2819 is a novel orally active acetylcholinesterase inhibitor (AChEI) developed for the treatment of Alzheimer's disease (AD). CHF2819 is a selective inhibitor of AChE, it is 115 times more potent against this enzyme than against butyrylcholinesterase (BuChE). Moreover, CHF2819 is more selective for inhibition of central (brain) AChE than peripheral (heart) AChE. In vivo CHF2819, 0.5, 1.5, and 4.5 mg/kg p.o., significantly and in dose-dependent manner increased acetylcholine (ACh) levels in hippocampus of young adult rats. Moreover, aging animals, with lower basal ACh levels than young adult rats, also exhibit a marked increase in hippocampal levels of this neurotransmitter after administ…

medicine.medical_specialtymedicine.drug_classPhenylcarbamatesPharmacologyHippocampusArticleCyclic N-Oxideschemistry.chemical_compoundNeurochemicalAlzheimer DiseaseDopamineInternal medicinemedicineAnimalsBiogenic MonoaminesAmino AcidsNeurotransmitterButyrylcholinesteraseCholinesterasePharmacologybiologybusiness.industryGlutamate receptoracetylcholinesterase inhibitors; alzheimer's disease; amino acids; chf2819; ganstigmine; neurotransmitters; rat hippocampusAcetylcholineRatsNeuropsychology and Physiological PsychologyEndocrinologyAcetylcholinesterase inhibitorchemistrybiology.proteinCarbamatesCholinesterase InhibitorsbusinessAcetylcholinemedicine.drug
researchProduct

The Inhibitory Effects of Prednisone, 16-Methylen-Prednisolone, and Acth on Con-A Induced Lymphokines (Interferon-Y) as Measured by the Chemiluminesc…

1988

When lymphocytes are stimulated with mitogens or antigens they are enhanced via a cascade of lymphokines to produce interferon-y (IFN-y). IFN-y augments the H2O2 secretion of human monocytes which indirectly can be measured by chemiluminescence. We tested prednisone, 16-methylen-prednisolone and ACTH for their effect to inhibit the Con-A induced stimulation of the chemiluminescence-activity. All three hormones inhibited significantly the stimulation: prednisone up to 52.5% (concentration = 150 micrograms/ml, p = 0.000005), 16-methylen-prednisolone up to 22.5% (concentration = 2.5 micrograms/ml, p = 0.006) and ACTH up to 33% (concentration = 10 micrograms/ml, p = 0.0036).

medicine.medical_specialtymedicine.drug_classPrednisoloneImmunologyDose-Response Relationship ImmunologicStimulationAdrenocorticotropic hormoneToxicologyMonocytesInterferon-gammaAdrenocorticotropic HormoneInternal medicineConcanavalin AmedicineHumansImmunology and AllergyInterferon gammaPharmacologybiologybusiness.industryMonocyteLymphokineHydrogen PeroxideGeneral Medicinemedicine.anatomical_structureEndocrinologyConcanavalin ALuminescent Measurementsbiology.proteinPrednisolonePrednisoneCorticosteroidbusinessmedicine.drugImmunopharmacology and Immunotoxicology
researchProduct

Cholesterol as stabilizer of the oxytocin receptor

2002

AbstractThe function of the oxytocin receptor system is strongly dependent on steroids as demonstrated by several physiological studies. One key element of this dependence on steroids may be the interaction of cholesterol and the oxytocin receptor. In this study, we show that cholesterol stabilizes the solubilized human oxytocin receptor against thermal inactivation and proteolytic degradation. In the absence of additional cholesterol, the soluble receptor inactivates within minutes. Maximal stabilization of the oxytocin receptor requires a continuous supply with cholesterol from a cholesterol-rich environment. A structure–activity analysis of various cholesterol analogues and their effect …

medicine.medical_specialtymedicine.medical_treatmentProteolysisGreen Fluorescent ProteinsBiophysicsTransfectionBiochemistrySteroidCell Linechemistry.chemical_compoundInternal medicineEndopeptidasesmedicineHumansDenaturation (biochemistry)ReceptorOxytocin receptormedicine.diagnostic_testCholesterolTemperatureTransfectionCell BiologyHydrogen-Ion ConcentrationOxytocin receptorDenaturationLuminescent ProteinsEndocrinologyCholesterolchemistrySolubilityCell cultureReceptors OxytocinProteolysislipids (amino acids peptides and proteins)hormones hormone substitutes and hormone antagonistsBiochimica et Biophysica Acta (BBA) - Biomembranes
researchProduct

Shortwave Ultraviolet Persistent Luminescence of Sr2MgSi2O7: Pr3+

2023

Currently, extensive research activities are devoted to developing persistent phosphors which extend beyond the visible range. In some emerging applications, long-lasting emission of high-energy photons is required; however, suitable materials for the shortwave ultraviolet (UV–C) band are extremely limited. This study reports a novel Sr2MgSi2O7 phosphor doped with Pr3+ ions, which exhibits UV–C persistent luminescence with maximum intensity at 243 nm. The solubility of Pr3+ in the matrix is analysed by X-ray diffraction (XRD) and optimal activator concentration is determined. Optical and structural properties are characterised by photoluminescence (PL), thermally stimulated lumi…

melilitethermostimulated luminescence (TSL)long-lasting luminescenceGeneral Materials Scienceelectron spin resonance (ESR)afterglowUVCMaterials
researchProduct

Inorganic Mercury Sequestration by a Poly(ethylene imine) Dendrimer in Aqueous Solution

2015

The interaction of the G-2 poly(ethylene imine) dendrimer L, derived from ammonia as initiating core, with Hg(II) and HgCl4 2− was studied in aqueous solution by means of potentiometric (pH-metric) measurements. Speciation of these complex systems showed that L is able to form a wide variety of complexes including 1:1, 2:1, 3:1 and 3:2 metal-to-ligand species, of different protonation states, as well as the anion complexes ((H7L)HgCl4) 5+ and ((H8L)HgCl4) 6+ . The stability of the metal complexes is very high, making L an excellent sequestering agent for Hg(II), over a large pH range, and a promising ligand for the preparation of functionalized activated carbons to be employed in the remedi…

mercuryImineInorganic chemistryPotentiometric titrationPharmaceutical Sciencechemistry.chemical_elementProtonationmercury dendrimers sequestration water contamination environmentArticleAnalytical Chemistrydendrimerspoly(ethylene imine)Metallcsh:QD241-441chemistry.chemical_compoundAmmoniacontaminationlcsh:Organic chemistryDendrimerDrug DiscoveryremediationPhysical and Theoretical ChemistryAqueous solutionMolecular StructureOrganic ChemistryMercury (element)chemistryChemistry (miscellaneous)visual_artPotentiometryvisual_art.visual_art_mediumMolecular MedicineEnvironmental PollutantsIminesPolyethylenesMolecules
researchProduct